BB

BB Biotech Portfolio holdings

AUM $3.98B
This Quarter Return
+15.43%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
AUM
$1.39B
AUM Growth
Cap. Flow
+$1.39B
Cap. Flow %
100%
Top 10 Hldgs %
84.97%
Holding
23
New
23
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 88.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$252M 18.12%
+2,150,186
New +$252M
IONS icon
2
Ionis Pharmaceuticals
IONS
$6.79B
$209M 15.04%
+7,769,172
New +$209M
GILD icon
3
Gilead Sciences
GILD
$140B
$190M 13.67%
+3,700,000
New +$190M
INCY icon
4
Incyte
INCY
$16.5B
$118M 8.49%
+5,357,149
New +$118M
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$100B
$112M 8.1%
+1,404,445
New +$112M
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$71.8M 5.17%
+778,126
New +$71.8M
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
$71.3M 5.14%
+1,449,706
New +$71.3M
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$54.5M 3.93%
+3,115,371
New +$54.5M
IMGN
9
DELISTED
Immunogen Inc
IMGN
$54.1M 3.9%
+3,262,094
New +$54.1M
ONXX
10
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$47.4M 3.42%
+546,500
New +$47.4M
HALO icon
11
Halozyme
HALO
$8.56B
$44.9M 3.23%
+5,646,519
New +$44.9M
INVA icon
12
Innoviva
INVA
$1.29B
$34.2M 2.47%
+888,244
New +$34.2M
ECYT
13
DELISTED
Endocyte, Inc. Common Stock
ECYT
$30.7M 2.21%
+2,339,345
New +$30.7M
OPTR
14
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
$20.9M 1.51%
+1,446,700
New +$20.9M
INFI
15
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$17.6M 1.27%
+1,089,828
New +$17.6M
ALNY icon
16
Alnylam Pharmaceuticals
ALNY
$58.5B
$14.1M 1.02%
+454,800
New +$14.1M
ACHN
17
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$13.7M 0.99%
+1,679,340
New +$13.7M
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.2B
$9.92M 0.71%
+178,028
New +$9.92M
MDCO
19
DELISTED
Medicines Co
MDCO
$9.32M 0.67%
+302,993
New +$9.32M
IDIX
20
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$4.51M 0.33%
+1,250,000
New +$4.51M
DNDN
21
DELISTED
DENDREON CORPORATION
DNDN
$4.18M 0.3%
+1,014,800
New +$4.18M
TSRX
22
DELISTED
TRIUS THERAPEUTICS INC COM STK (DE)
TSRX
$2.27M 0.16%
+280,000
New +$2.27M
GEVA
23
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$2.25M 0.16%
+53,549
New +$2.25M